AVANOS MEDICAL Files 8-K on Financial Condition
Ticker: AVNS · Form: 8-K · Filed: Feb 20, 2024 · CIK: 1606498
| Field | Detail |
|---|---|
| Company | Avanos Medical, INC. (AVNS) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, SEC-filing
TL;DR
**AVANOS MEDICAL just dropped an 8-K on its financials, so keep an eye out for details on their performance.**
AI Summary
AVANOS MEDICAL, INC. filed an 8-K on February 20, 2024, to report on its results of operations and financial condition. The filing, under SEC file number 001-36440, indicates that the company, based in Alpharetta, Georgia, is providing current information as required by the Securities Exchange Act of 1934. This report serves to update investors on the company's financial performance and operational status.
Why It Matters
This filing provides investors with current information on AVANOS MEDICAL, INC.'s financial health and operational performance, which can influence investment decisions and market perception.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial results and does not indicate any specific new risks.
Key Players & Entities
- AVANOS MEDICAL, INC. (company) — registrant
- February 20, 2024 (date) — date of report
- Delaware (location) — state of incorporation
- 001-36440 (other) — Commission file number
- Alpharetta, Georgia (location) — principal executive offices
FAQ
What is the purpose of this 8-K filing by AVANOS MEDICAL, INC.?
The 8-K filing by AVANOS MEDICAL, INC. is to report on the company's Results of Operations and Financial Condition, as well as Financial Statements and Exhibits, as of February 20, 2024.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is February 20, 2024.
What is the Commission file number for AVANOS MEDICAL, INC.?
The Commission file number for AVANOS MEDICAL, INC. is 001-36440.
Where are AVANOS MEDICAL, INC.'s principal executive offices located?
AVANOS MEDICAL, INC.'s principal executive offices are located at 5405 Windward Parkway, Suite 100 South, Alpharetta, Georgia 30004.
Under which act is this current report filed?
This current report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 510 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-02-20 07:05:33
Key Financial Figures
- $0.01 — nge on which registered Common Stock - $0.01 Par Value AVNS New York Stock Exchange
Filing Documents
- avns-20240220.htm (8-K) — 27KB
- avns4q2023form8-kex991.htm (EX-99.1) — 854KB
- avanoslogoa08.jpg (GRAPHIC) — 15KB
- avns-20240220_g1.jpg (GRAPHIC) — 15KB
- 0001606498-24-000016.txt ( ) — 1110KB
- avns-20240220.xsd (EX-101.SCH) — 2KB
- avns-20240220_lab.xml (EX-101.LAB) — 25KB
- avns-20240220_pre.xml (EX-101.PRE) — 13KB
- avns-20240220_htm.xml (XML) — 3KB
02 Results of Operation and Financial Condition
Item 2.02 Results of Operation and Financial Condition On February 20, 2024, Avanos Medical, Inc. (the "Company") issued a press release announcing its results of operations for the three months and year ended December 31, 2023. A copy of the press release is furnished herewith as Exhibit 99.1. The information contained in this Item 2.02 of this Current Report, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as otherwise expressly stated in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits. The following exhibits are filed with this Current Report on Form 8-K: Exhibit No. Description 99.1 Press Release issued by Avanos Medical, Inc. on February 20, 2024 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVANOS MEDICAL, INC. Date: February 20, 2024 By: /s/ Mojirade James Mojirade James Senior Vice President and General Counsel